Production (Stage)
Inspire Medical Systems, Inc.
INSP
$143.21
-$2.74-1.88%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 840.11M | 802.80M | 755.59M | 705.71M | 660.91M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 840.11M | 802.80M | 755.59M | 705.71M | 660.91M |
| Cost of Revenue | 128.94M | 122.99M | 115.05M | 107.04M | 101.45M |
| Gross Profit | 711.17M | 679.82M | 640.54M | 598.67M | 559.47M |
| SG&A Expenses | 548.28M | 529.61M | 512.20M | 495.06M | 475.59M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 790.30M | 766.72M | 742.10M | 720.00M | 696.90M |
| Operating Income | 49.82M | 36.08M | 13.50M | -14.29M | -35.99M |
| Income Before Tax | 71.97M | 58.45M | 37.06M | 8.53M | -14.05M |
| Income Tax Expenses | 5.46M | 4.94M | 4.01M | 2.52M | 1.68M |
| Earnings from Continuing Operations | 66.51 | 53.51 | 33.05 | 6.01 | -15.73 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 66.51M | 53.51M | 33.05M | 6.01M | -15.73M |
| EBIT | 49.82M | 36.08M | 13.50M | -14.29M | -35.99M |
| EBITDA | 58.57M | 42.63M | 18.39M | -10.48M | -32.90M |
| EPS Basic | 2.23 | 1.79 | 1.11 | 0.20 | -0.54 |
| Normalized Basic EPS | 1.51 | 1.22 | 0.78 | 0.18 | -0.30 |
| EPS Diluted | 2.16 | 1.72 | 1.07 | 0.18 | -0.55 |
| Normalized Diluted EPS | 1.47 | 1.18 | 0.76 | 0.17 | -0.31 |
| Average Basic Shares Outstanding | 119.14M | 119.05M | 118.74M | 118.23M | 117.73M |
| Average Diluted Shares Outstanding | 122.11M | 121.41M | 120.89M | 119.63M | 118.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |